DRUG GUIDELINE

Urokinase- Thrombolysis Of Peripheral Arterial Thrombus

SCOPE (Area): ICU, Cardiovascular Suite

SCOPE (Staff): Medical, Nursing, Pharmacy

Printed versions of this document SHOULD NOT be considered up to date / current

Exclusions

Paediatrics (seek Paediatrician advice), all areas except Cardiovascular Unit and Intensive Care Unit

Preamble

See Appendix 1 for full version of this Drug Guideline

References

	Alfred Health (2018, Nov). Thrombolysis Management with Urokinase Radiology and Ward Guideline. Alfred Health. Retrieved January 16, 2023 from https://app.prompt.org.au/search
	Barwon Health (2021, June). Intra Vascular Urokinase. Barwon Health. Retrieved January 16, 2023 from https://app.prompt.org.au/search
	Datapharm Ltd, (2023, Jan). Summary of Product Characteristics: Syner-KINASE powder for solution for injection/infusion. Retrieved January 16, 2023 from https://www.medicines.org.uk/emc.
	Endovascular Today Europe (2019). Example of a Protocol for Intra-arterial Thrombolysis, Supplement to Endovascular Today March 2019; 7(2), 10-11. Available from: https://assets.bmctoday.net/evtoday/pdfs/eteu1118_EumedicaSupp_sec%202.pdf
	IBM Corporation. (2023). IBM Micromedex, Urokinase. Retrieved January 16, 2023, from https://www.micromedexsolutions.com.acs.hcn.com.au/micromedex
	Northern Health (2021, Nov). Vascular Procedural Thrombolysis. Northern Health. Retrieved January 16, 2023 from https://app.prompt.org.au/search
	Peninsula Health (2023, Feb). Urokinase For Interventional Radiology Adult Drug Administration Guideline. Retrieved October 30, 2023 from https://app.prompt.org.au/search
	The Society of Hospital Pharmacists of Australia. 2023. Australian Injectable Drugs Handbook (9th ed.). Collingwood: The Society of Hospital Pharmacists of Australia. Retrieved July 31, 2023 from https://aidh.hcn.com.au/browse/about_aidh
	Wolters Kluwer Clinical Drug Information, Inc. (2023) UpToDate, Drug Interactions. Retrieved January 16, 2023, http://www.uptodate.com/drug-interaction
	Wolters Kluwer. (2023) Lexicomp, Pharmacology & Pharmacokinetics. Retrieved January 16, 2023, from https://online.lexi.com.acs.hcn.com.au/lco/action/home

Appendix

Appendix 1 - Urokinase Drug Guideline

Reg Authority: Medication Safety & Governance Committee (MSGC)	Date Effective: 30/10/2023
Review Responsibility: Pharmacist - Rotational	Date for Review: 30/10/2026

Urokinase- Thrombolysis Of Peripheral Arterial Thrombus - DRG0057 - Version: 2 - (Generated On: 01-07-2025 05:52)

Exclusions

Preamble

See Appendix 1 for full version of this Drug Guideline

Related Documents

References

Appendix